Skip to main content
. 2022 Jan 15;12(1):122. doi: 10.3390/life12010122

Table 1.

Effectiveness of telemedicine in lung diseases (reviews and meta-analyses).

Disease(s) Outcomes References
COPD Reduction in emergency room visits
Exacerbation-related readmissions (if TM more than 6 months)
Exacerbation-related hospital days
Quality of life: St. George’s Respiratory Questionnaire (SGRQ) score
Early detection of acute exacerbations of COPD
Health-related outcomes
[25,26,27,28]
COPD Mortality, all-cause readmissions, rate of exacerbation-related readmissions, all-cause hospital days, time to first hospital readmission, anxiety, depression, exercise capacity [25]
COPD/asthma Self-management (SM)
SM supported by telehealth produces reduction in healthcare utilization
[25,29,30,31]
COPD Oxygen saturation measurements utility [32]
Asthma Symptoms and total dose of oral prednisolone [33]
Respiratory diseases Utility of noninvasive portable Digital Technologies [34]
COPD Use of Forced expiratory volume assessed daily, resting respiratory rate, respiratory sounds, end-tidal carbon dioxide level [28]
COPD/asthma Adherence to therapy [35]
Chronic Respiratory Failure Reduction in emergency room visits, exacerbation-related readmissions, GP urgent calls, and hospitalizations [36]